Table of contents

Current Concepts In The Management Of Gynecologic Tumors

• Introduction (1 September, 1996)

  R. C. Young
• Comparison of combination therapy with paclitaxel Taxol® and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study (1 September, 1996)

  W. P. McGuire, W. J. Hoskins, M. F. Brady, P. R. Kucera, E. E. Partridge, K. Y. Look, D. L. Clarke-Pearson, M. Davidson
• Paclitaxel (Taxol®) plus carboplatin as first-line treatment for advanced ovarian cancer (1 September, 1996)

  R. F. Ozols
• Multimodality therapy of early-stage (FIGO I-II) ovarian cancer: review of surgical management and postoperative adjuvant treatment (1 September, 1996)

  N. Colombo, A. Maggioni, L. Bocciolone, S. Rota, M. G. Cantù, C. Mangioni
• Novel treatments of cervical cancer (1 September, 1996)

  E. Mohamed, S. Piamsomboom, A. P. Kudelka, J. Kavanagh
• Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study (1 September, 1996)

  D.S. Alberts, P. Y. Liu, E. V. Hannigan, R. O'Toole, S. D. Williams, J.A. Young, E. W. Franklin, D. L. Clarke-Pearson, V. K. Malviya, B. Dubeshter, W. J. Hoskins, M. D. Adelson, R. D. Alvarez, J. O'Sullivan, D. B. Sparks, J. Quade, M. L. Rothenberg
• The role of intervention debulking surgery in advanced epithelial ovarian cancer: an EORTC Gynecological Cancer Cooperative Group study (1 September, 1996)

  M.E.L. Van Der Burg, M. Van Lent, M. Buyse, A. Kobierska, A. Maggioni, G. Favalli, A. J. Lacave, M. Nardi, J. Renard, S. Pecorelli